{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:49:54Z","timestamp":1761407394450,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.sleep.2023.11.022","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:53:47Z","timestamp":1700873627000},"page":"328-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study"],"prefix":"10.1016","volume":"113","author":[{"given":"Aatif M.","family":"Husain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis C.","family":"Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen B.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas S.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Macfadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Candler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"The international classification of sleep disorders","key":"10.1016\/j.sleep.2023.11.022_bib1"},{"year":"2014","series-title":"The international classification of sleep disorders","key":"10.1016\/j.sleep.2023.11.022_bib2"},{"key":"10.1016\/j.sleep.2023.11.022_bib3","volume":"3","author":"Kornum","year":"2017","journal-title":"Narcolepsy. Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.022_bib4","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/cts.13087","article-title":"Pharmacokinetics, bioavailability, and bioequivalence of lower-sodium oxybate in healthy participants in 2 open-label, randomized, crossover studies","volume":"14","author":"Chen","year":"2021","journal-title":"Clin Transl Sci"},{"year":"2023","series-title":"Xywav\u00ae (calcium, magnesium, potassium, and sodium oxybates) oral solution, CIII [prescribing information]","key":"10.1016\/j.sleep.2023.11.022_bib5"},{"issue":"19","key":"10.1016\/j.sleep.2023.11.022_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJM199511093331917","article-title":"Declaring the sodium content of drug products","volume":"333","author":"Szarfman","year":"1995","journal-title":"N Engl J Med"},{"unstructured":"US Food and Drug Administration Quantitative labeling of sodium, potassium, and phosphorus for human over-the-counter and prescription drug products. Guidance for industry. US Food and Drug Administration Available at:. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/quantitative-labeling-sodium-potassium-and-phosphorus-human-over-counter-and-prescription-drug; 2022. [Accessed 15 May 2023].","key":"10.1016\/j.sleep.2023.11.022_bib7"},{"unstructured":"US Food and Drug Administration Clinical review for Binosto, NDA 202344. US Food and drug administration Available at:. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202344Orig1s000MedR.pdf; 2012. [Accessed 15 May 2023].","key":"10.1016\/j.sleep.2023.11.022_bib8"},{"unstructured":"Clinical superiority findings. US Food and Drug Administration; 2021. Available at: https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/clinical-superiority-findings. [Accessed 15 May 2023].","key":"10.1016\/j.sleep.2023.11.022_bib9"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.022_bib10","doi-asserted-by":"crossref","first-page":"zsaa206","DOI":"10.1093\/sleep\/zsaa206","article-title":"Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy","volume":"44","author":"Bogan","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.022_bib24","first-page":"65","article-title":"Effectiveness and tolerability in people with narcolepsy transitioning from high-sodium oxybate to low-sodium oxybate: data from the real-world TENOR study.Sleep","volume":"109","author":"Bae","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.sleep.2023.11.022_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.sleep.2021.06.008","article-title":"The Nexus Narcolepsy Registry: methodology, study population characteristics, and patterns and predictors of narcolepsy diagnosis","volume":"84","author":"Ohayon","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.11.022_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101440","article-title":"Cardiovascular disorders in narcolepsy: review of associations and determinants","volume":"58","author":"Jennum","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"15","key":"10.1016\/j.sleep.2023.11.022_bib13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2016.07.745","article-title":"Sodium intake and all-cause mortality over 20 years in the trials of hypertension prevention","volume":"68","author":"Cook","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7599","key":"10.1016\/j.sleep.2023.11.022_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.sleep.2023.11.022_bib15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of salt substitution on cardiovascular events and death","volume":"385","author":"Neal","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.022_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-sodium collaborative research group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.022_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/pds.1701","article-title":"Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication","volume":"18","author":"Ubeda","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.022_bib18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/HJH.0000000000001733","article-title":"Effect of effervescent paracetamol on blood pressure: a crossover randomized clinical trial","volume":"36","author":"Benitez-Camps","year":"2018","journal-title":"J Hypertens"},{"issue":"18","key":"10.1016\/j.sleep.2023.11.022_bib19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/eurheartj\/ehac059","article-title":"Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension","volume":"43","author":"Zeng","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sleep.2023.11.022_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.sleep.2016.04.004","article-title":"Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study","volume":"33","author":"Black","year":"2017","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.022_bib21","doi-asserted-by":"crossref","first-page":"zsad161","DOI":"10.1093\/sleep\/zsad161","article-title":"Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study","volume":"46","author":"Ben-Joseph","year":"2023","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.022_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40263-022-00926-0","article-title":"Changes in cataplexy frequency in a clinical trial of lower-sodium oxybate with taper and discontinuation of other anticataplectic medications","volume":"36","author":"Dauvilliers","year":"2022","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.022_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5664\/jcsm.4598","article-title":"Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy","volume":"11","author":"Bogan","year":"2015","journal-title":"J Clin Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723004409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723004409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:45:08Z","timestamp":1761407108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723004409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"alternative-id":["S1389945723004409"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.11.022","relation":{},"ISSN":["1389-9457"],"issn-type":[{"type":"print","value":"1389-9457"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}